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Abstract 
Background: Treatment of myocardial infarction with mesenchymal stem cells (MSCs) has proven beneficial effects 
in both animal and clinical studies. Engineered silica nanoparticles (SiO2-NPs) have been extensively used as contrast 
agents in regenerative medicine, due to their resistance to degradation and ease of functionalization. However, there 
are still controversies on their effective biosafety on cellular systems. In this perspective, the aims of the present study 
are: 1) to deeply investigate the impact of amorphous 50 nm SiO2-NPs on viability and function of human bone 
marrow-derived MSCs (hMSCs); 2) to optimize a protocol of harmless hMSCs labelling and test its feasibility in a beat-
ing heart model.
Results: Optimal cell labelling is obtained after 16 h exposure of hMSCs to fluorescent 50 nm SiO2-NPs (50 µg mL
−1); 
interestingly, lysosomal activation consequent to NPs storage is not associated to oxidative stress. During prolonged 
culture hMSCs do not undergo cyto- or genotoxicity, preserve their proliferative potential and their stemness/differ-
entiation properties. Finally, the bright fluorescence emitted by internalized SiO2-NPs allows both clear visualization of 
hMSCs in normal and infarcted rat hearts and ultrastructural analysis of cell engraftment inside myocardial tissue.
Conclusions: Overall, 50 nm SiO2-NPs display elevated compatibility with hMSCs in terms of lack of cyto- and geno-
toxicity and maintenance of important features of these cells. The demonstrated biosafety, combined with proper cell 
labelling and visualization in histological sections, make these SiO2-NPs optimal candidates for the purpose of stem 
cell tracking inside heart tissue.
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Background
Acute myocardial infarction (MI) is a pathological 
condition that often results in large-scale loss of car-
diac muscle. Interestingly, several works documented 
that ischemic cardiac injury is able to stimulate the 
recruitment into the myocardium of circulating stem 
cells (SCs) [1, 2]. In the context of MI therapy, a vast 
number of preclinical studies observed significant car-
diac improvement after mesenchymal SCs (MSCs) 
transplantation [3, 4] and regenerative therapy using 
MSCs has been recently detailed in several clinical tri-
als [5–7]. However, drawbacks reside on the complexity 
to accomplish proper cell delivery and in the still poor 
understanding of the exact mechanisms at the base of cell 
distribution inside the injured tissue. The development of 
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safe imaging techniques is therefore of great interest to 
allow long-term analysis of cell survival, migration and 
engraftment, facilitating the understanding of treatment 
outcomes [8, 9]. Several engineered nanoparticles (NPs), 
defined as ultrafine objects with a size less than 100 nm 
[10], have already been tested in preclinical studies to 
follow MSCs inside the cardiac milieu [11, 12]. Among 
them, silica NPs (SiO2-NPs) possess unique properties of 
biocompatibility, stability over time and easily adjustable 
properties, for example size, morphology, porosity and 
surface chemistry [13].
To date, SiO2-NPs have already been used in animal 
studies to follow the fate of MSCs inside the host [14, 
15]. However, despite promising results, there is consid-
erable controversy about the safety of silica nanomateri-
als on cellular systems, mainly due to differences in the 
synthesis method, size and shape of the platforms [16, 
17]. Therefore, for the safe application of SiO2-NPs for 
SCs tracking it is crucial to conduct systematic studies 
to assess their toxicological profile in terms of potential 
interference with self-renewal and differentiation pro-
grams of SCs and eventual induced genotoxicity [18, 19]. 
Finally, it is necessary to obtain a good level of intracellu-
lar staining in order to gain information on the distribu-
tion of SCs inside host tissue. In this scenario, SiO2-NPs 
functionalized with fluorescent molecules have been 
extensively used for optical imaging, as enclosed dye 
molecules show a higher quantum yield and enhanced 
photostability respect to the same fluorophores freely 
dissolved in medium [20, 21].
Based on these assumptions, the rationale of the pre-
sent study was to test safety, biocompatibility and feasi-
bility to track SCs into tissue and organs of our lab-made 
amorphous fluorescent SiO2-NPs of uniform spherical 
size (50 ±  2  nm), do not bearing any capping agent and 
exposing at their surface only hydroxyl groups (silanols) 
and siloxane bridges [22]. In view of this purpose, in vitro 
analysis of labelled human bone marrow-derived MSCs 
(hMSCs) was assessed to deepen the aspect of toxicity and 
alteration of mesenchymal properties eventually related to 
long-term interaction of SiO2-NPs with these cells. More-
over, hMSCs labelled with fluorescent SiO2-NPs were 
injected in ex vivo perfused rat hearts to investigate their 
distribution and engraftment inside ventricular tissue.
Results and discussion
In vitro evaluation of the biosafety of 50 nm SiO2‑NPs 
on hMSCs
hMSCs exposed for 16 h–50 nm SiO2‑NPs 50 µg·mL−1 display 
good labeling, enclose SiO2‑NPs inside lysosomes and are not 
subjected to oxidative stress
Previous works from our laboratory documented that 
50 nm SiO2-NPs at the dose of 20 µg·mL−1 were taken 
by hMSCs via active endocytosis, stored inside late 
endosomes and lysosomes and maintained elevated 
photostability at the acidic pH typical of these orga-
nelles [23, 24]. However, for the final purpose of visu-
alizing labelled cells inside rat hearts increased dose 
and incubation time need to be tested, due to the small 
magnification necessary to appreciate the cells inside 
the whole tissue. Indeed, in the present study confo-
cal analysis after 16  h exposure of hMSCs to the dose 
of 50  µg·mL−1 (here referred as t0) produced appro-
priate and bright fluorescent staining (Fig.  1a, arrow-
heads). Correspondingly, flow cytometry analysis 
(Fig. 1b) revealed that the mean number of labelled cells 
was 95.78 ± 1.27 %, indicating that 50 nm SiO2-NPs at 
the dose of 50  µg·mL−1are optimal contrast agents for 
hMSCs. Furthermore, despite the different dose and 
incubation time, confocal analysis of SiO2-NPs-exposed 
hMSCs labelled with Lysotracker Green confirmed 
that these NPs were stored inside lysosomes (Fig.  1d), 
according with the findings obtained in our earlier study 
[23].
Nevertheless, marked differences in lysosomal mor-
phology and distribution were observed between 
untreated (UT) hMSCs and cells exposed to SiO2-NPs, 
as the former (UT cells) presented few and small lys-
osomes prevalently localized around nuclei (Fig.  1c, 
arrows), whereas the latter (SiO2-NPs-treated cells) 
displayed an increase of these organelles. Indeed, lys-
osomes were higher in number and assumed the aspect 
of vacuoles covering a greater portion of the cell body 
(Fig. 1d, arrows). These findings were in agreement with 
a recent work showing that 50  nm SiO2-NPs induced 
high vacuolization of human cerebral endothelial cells 
due to marked autophagic response as well as lysoso-
mal involvement [25]. Interestingly, elevated reactive 
oxygen species (ROS) levels have been reported as one 
of the most important mechanisms of toxicity mediated 
by internalized SiO2-NPs in several cell types [17, 26], 
therefore, associated autophagy might be activated to 
limit ROS-dependent damage of cellular structures [27]. 
However, in the present study internalized SiO2-NPs did 
not induce any appreciable increase of ROS in hMSCs 
at t0 (Fig. 1e). This apparent discrepancy with literature 
data might be due to the fact that bone marrow-derived 
MSCs are highly resistant to oxidative damage due to 
the well-known constitutive expression of the biochemi-
cal machinery to scavenge ROS [28]; more likely, under 
oxidative conditions these cells can activate a defensive 
system probably dependent on marked increase of endo-
somal activity [29, 30].
Taken together, these data suggest that after SiO2-NPs 
internalization hMSCs might undergo elevated lysosomal 
involvement in the absence of an evident ROS stress.
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Internalized SiO2‑NPs are not associated to cyto‑ 
and genotoxic stress in cultured hMSCs and do not alter their 
proliferative potential
Demonstrated the absence of a detectable SiO2-NPs 
-induced oxidative stress at t0, the possibility of long-
term toxicity was then investigated by analysing cell 
survival during prolonged in  vitro culture (7  days) via 
propidium iodide (PI) staining (Fig. 2a, b). UT- and SiO2-
NPs -treated hMSCs displayed a similar small amount 
of dead cells, as can be seen in the representative flow 
cytometry histograms at t0 (Fig.  2a, top populations). 
Quantification of percentage cell survival then revealed 
the same trend also after 1 (R 1d), 3 (R 3d) and 7 (R 7d) 
days of recovery in standard medium (Fig.  2b), thereby 
indicating that SiO2-NPs did not lead to significant cyto-
toxicity in hMSCs both after their uptake and at later 
time points of in vitro culture.
Another sign of SiO2-NPs-dependent toxicity might 
be their interaction with components of the nucleus 
or the genome itself. However, to date there are still 
limited and contrasting evidences in literature about 
genotoxicity, likely depending on the different cellular 
models, silica NPs types and/or concentrations used 
[31, 32]. In the present study, reconstructions of confo-
cal acquisitions along the Z-axis indicated that SiO2-NPs 
did not localize inside nuclei during the time course of 
in  vitro culture (Additional file  1 Panels A–D), thereby 
excluding a direct interaction between these NPs and 
the cell genome. Furthermore, immunofluorescence 
experiments of the phosphorylation at Ser136 of his-
tone H2AX (γH2AX) (Fig.  2c, d), a specific marker of 
DNA double-strand-breaks (DSBs) [33], showed that 
at t0 both UT- and SiO2-NPs-hMSCs displayed very 
few γH2AX foci respect to irradiation at 10  Gy, which 
was used as a positive control for the reaction (Addi-
tional file 1 Panel E, arrows). Subsequent quantification 
highlighted that positive cells for γH2AX foci varied 
between 14.72 ± 1.04 and 16.78 ± 1.3 % for UT-hMSCs 
and between 14.85 ± 1.96 and 15.83 ± 1.47 % for SiO2-
NPs-cells (Fig. 2g), with a comparable mean number of 
foci between the two conditions (Additional file 1 Panel 
F), thus demonstrating that cultured hMSCs did not 
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Fig. 1 16 h exposure of hMSCs to 50 nm SiO2-NPs 50 µg·mL−1: cell labelling, intracellular localization and ROS production. a Staining of hMSCs 
with SiO2-NPs (red) after 16 h (t0). Nuclei were counterstained with Hoechst-33342 (blue). Magnification 40×, scale bar 50 µm. b Representative flow 
cytometry histogram of percentage hMSCs labelled with SiO2-NPs at t0. Untreated (UT) cells (white histogram) result negative for red fluorescence 
(FL-2), whereas labelled cells (SiO2-NPs, hatched histogram) emit strong red fluorescence due to internalized SiO2-NPs. c, d Confocal acquisitions of 
UT- (c) and SiO2-NPs-treated (d) hMSCs at t0 labelled with Lysotracker Green to reveal lysosomal compartments. Co-localization between fluo-
rescent SiO2-NPs (red) and Lysotracker (green) was displayed by the system as yellow. Magnification 63×, scale bar 20 µm. e ROS production at t0 
evaluated with DCFH-DA assay. hMSCs treated for 2 h with H2O2 600 µmol L
−1 served as positive control. Fluorescent emission from each sample 
was normalized by the mean UT value. ** p < 0.01 vs. UT and ## p < 0.01 vs. SiO2-NPs
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undergo basal increase of DSBs. Altogether, present data 
confirm that 16  h exposure to 50  nm SiO2-NPs at the 
dose of 50 µg·mL−1 is safe and not associated to cyto- or 
genotoxic effects in hMSCs. This is also in line with the 
low ROS level observed at t0 (Fig. 1e).
Finally, we analyzed the impact of SiO2-NPs on the pro-
liferative potential of these cells. Representative immu-
nofluorescence images show that at t0 and R 1d the 
majority of SiO2-NPs -treated hMSCs displayed consid-
erable amounts of intracellular red fluorescence due to 
the presence of SiO2-NPs (Fig.  3a, b). However, at R 3d 
and R 7d time points a progressive decrease of fluores-
cent NPs per cell was observed (Fig. 3c, d). Quantification 
of these experiments as percentage labelled cells respect 
to the total population (Fig.  3e) revealed that the mean 
value at t0 was 99.22 ± 0.07 %, in accordance with flow 
cytometry results (Fig.  1b). Furthermore, a significant 
decrease at R 3d and R 7d was observed (both p < 0.01 vs. 
t0), with 64.86 ± 0.51 % of labelled cells at R 7d. Remark-
ably, co-localization with lysosomes was observed 
throughout the time course of in vitro cell culture (mean 
Pearson’s R values: 0.671 ± 0.01 for t0, 0.670 ± 0.02 for 
R1d, 0.693  ±  0.02 for R3d and 0.652  ±  0.04 for R7d), 
despite progressive decrease of internalized NPs per cell 
(Additional file 2 Panels A–D, arrows).
It is plausible that time-dependent reduction of fluores-
cent SiO2-NPs inside hMSCs is due to their redistribu-
tion into newly formed/daughter cells. In fact, the in vitro 
proliferation rate of hMSCs was not affected by internal-
ized SiO2-NPs (Fig.  3f ), in particular a gradual increase 
of cumulative population doubling levels (CPDL) was 
observed, reaching at R 7d 5.06  ±  0.46 for UT- and 
5.45 ± 0.7 for SiO2-NPs-treated cells. As a further confir-
mation, the time-dependent decline of intracellular NPs 
was markedly inhibited when labelled hMSCs were cul-
tured in complete DMEM supplemented with 1  % FBS, 
a specific condition that minimize cell divisions during 
culture (Additional file 2 Panels E–F). These data are in 
agreement with previous studies showing a dilution of 
loaded SiO2-NPs upon cell division in both human ade-
nocarcinomic lung epithelial and murine pre-osteoblast 
cells [34–36].
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Fig. 2 Assessment of cytotoxic and genotoxic stress in cultured hMSCs. a Representative flow cytometry histograms of UT- and SiO2-NPs -treated 
hMSCs at t0: forward scatter (FS) in function of propidium iodide fluorescence (PI) allows discriminating living cells (bottom population) from dead 
cells (top population). b Quantification of hMSCs viability during in vitro culture, represented as percentage variation respect to UT cells at the same 
time point. c, d Representative immunofluorescence experiments for γH2AX in UT- and SiO2-NPs -treated hMSCs at t0. Magnification 63×, scale bar 
20 µm. e Quantification of percentage positive cells for nuclear γH2AX foci during culture
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Taken together, our results confirm that SiO2-NPs had 
no impact on the typical proliferation rate of hMSCs.
Treatment with SiO2‑NPs s does not modify stemness 
properties of cultured hMSCs
Another possible influence of SiO2-NPs on hMSCs func-
tion might be the alteration of their stemness. In par-
ticular, hMSCs are characterized by the expression of a 
well-known set of surface antigens and by the ability to 
differentiate into chondrocytes, adipocytes and osteo-
blasts and to commit to other cell lineages, among them 
neurons and cardiomyocytes [37–40].
In this study, flow cytometry analysis of a specific set 
of surface antigens on both UT- and SiO2-NPs -treated 
hMSCs showed that at t0 and at R 7d (Fig. 4a, b) inter-
nalized SiO2-NPs did not change the expression of the 
specific markers CD90, CD29, CD166, CD105, CD44 and 
CD73. Moreover, labelled hMSCs remained negative for 
CD34, CD45 and CD107, HLA-DR and CD14 surface 
molecules. Analogous results were obtained at R 1d and 
R 3d time points (data not shown).
Importantly, the differentiation potential of hMSCs 
was not affected by their exposure to 50 nm SiO2-NPs; 
indeed, cell differentiation towards the adipogenic line-
age was identical between UT- and SiO2-NPs-exposed 
cells, as both experimental groups acquired the round 
morphology typical of adipocytes (Additional file  3, 
Panels A–B, arrows) and produced a similar amount 
of specific intracellular lipid deposits stained with Oil 
red (Fig.  4c, d). Also osteogenic differentiation con-
firmed absence of differences between UT- and treated 
hMSCs, which at terminal induction resulted com-
pletely covered by a dense extracellular matrix typical 
of osteocytes (Additional file  3 Panels C–D) mostly 
made up of calcium deposits stained by Alizarin red 
(Fig. 4e, f ).
Hence, these results suggest that intracellular accu-
mulation of SiO2-NPs did not influence the stemness 
features of hMSCs, in line with previous data with the 
same SiO2-NPs given at lower dose and incubation 
time [23]. Finally, together with lack of cytotoxicity 
and unaltered proliferation rate during culture, these 
findings represent an important step-forward in dem-
onstrating the biosafety of these amorphous NPs as 
suitable contrast agents for in  vitro labeling of MSCs, 
in a perspective of in vivo application.
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Fig. 3 SiO2-NPs persistence in cultured hMSCs and assessment of their proliferation potential. a–d Distribution of SiO2-NPs (red) in hMSCs at t0 (a), 
R 1d (b), R 3d (c) and R 7d (d) time points. Nuclei were counterstained with Hoechst-33342 (blue). Magnification 40×, scale bar 50 µm. e Quanti-
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-treated hMSCs. For each time point, cells were counted to determine the “Cumulative Population Doubling Level” (CPDL) as an index of prolifera-
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Fig. 4 Assessment of stemness and differentiation potential in cultured hMSCs. Immunophenotypic characterization of UT and SiO2-NPs-treated 
hMSCs at t0 (a) and R 7d (b). An anti-isotype IgG was used as negative control for the reaction. c, d Representative images of UT (c) and SiO2-NPs 
(d) cells after 18 days of adipose differentiation. Lipid vacuoles are stained with Oil Red. Magnification 10×, scale bar 100 µm. (e, f) Representative 
pictures of UT- (e) and SiO2-NPs -exposed (f) hMSCs after 21 days of osteogenic differentiation. Alizarin Red was used to reveal extracellular deposi-
tion of calcium salts. Magnification 10×, scale bar 100 µm
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Feasibility of 50 nm SiO2‑NPs to track hMSCs inside the 
heart
After the profound characterization of the impact of 
50 nm SiO2-NPs on viability, proliferation and stemness 
properties of in vitro cultured hMSCs, a further impor-
tant aim of the present study was to ascertain the trace-
ability of injected SCs in the challenging condition of a 
beating heart, subjected or not to ischemia/reperfu-
sion (I/R). To this aim an ex vivo model of perfused rat 
heart was used. Cells employed for these investigations 
were harvested at t0, as this time point allowed obtain-
ing almost the totality of the cells stained with 50  nm 
SiO2-NPs with no interference of culture-dependent 
dilution of internalized NPs, seen above (Fig.  3). In 
non-ischemic hearts, reconstruction of a representative 
transverse section highlighted that labelled cells, injected 
into the myocardium apex, were widespread distributed 
inside the walls of both right and left ventricles (Fig. 5a). 
Focus on a specific low magnification field underlined 
that hMSCs were clearly labelled by internalized fluores-
cent SiO2-NPs (Fig. 5b, arrowheads). In addition, confo-
cal analysis at higher magnification (Fig. 5c) and volume 
reconstruction of a particular area of the same field 
(Fig.  5d, arrowheads) confirmed that cells were roughly 
dispersed inside the tissue, as often co-localization of 
one nucleus per labelled cell was observed. Concerning 
infarcted hearts, cells were injected into the apex 30 min 
after the ligation of the left descending coronary artery 
(LDCA) was removed. In these conditions, the pattern 
of cell distribution within the left ventricle myocardium 
Fig. 5 Imaging of SiO2-NPs -labelled hMSCs in normally perfused rat hearts. a Reconstruction of a 10 µm transverse slice (juxtaposition of conse-
quent stacks of 5× magnification) to show the localization of labelled hMSCs in normal ventricles. White points: clusters of hMSCs. Red line: perim-
eter of cell distribution inside normal ventricles. b Subset showing spare distribution of labelled hMSCs (red) inside cardiac tissue. Magnification 5×, 
scale bar 200 µm. c Representative confocal reconstruction with superposition of bright field, hMSCs (red) and nuclei (blue). The white dotted line 
limits the perimeter of the volume illustration showed in (d), where arrowheads stress the co-localization between labelled hMSCs (red) and nuclei 
(blue)
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depicted a major concentration of hMSCs close to the I/R 
lesion (Fig. 6a, white points) and the bright red fluores-
cence emitted by internalized SiO2-NPs underlined larger 
cell clusters (Fig. 6b, arrowheads). Higher magnification 
analysis (Fig. 6c) and volume reconstruction of a specific 
field (Fig. 6d, arrowheads) then revealed a higher number 
of nuclei co-localizing with red fluorescent cells respect 
to normally perfused hearts. 
Notably, the peculiar distribution of MSCs inside nor-
mal and infarcted hearts was already evidenced by our 
previous work in which also rat bone marrow-derived 
MSCs were spread in normal hearts and more aggre-
gated inside injured areas [41]. Hence, this finding might 
be considered as another confirmation that internalized 
SiO2-NPs do not alter the overall phenotype of hMSCs.
Finally, confocal 100× analysis of a representative nor-
mal heart section was assessed to clarify the ultrastruc-
ture of labelled hMSCs inside heart tissue (Fig. 7). 100× 
magnification and staining of cardiac tissue with sarcom-
eric α-actinin allowed to better appreciate red fluorescent 
SiO2-NPs entrapped inside hMSCs (Fig.  7a). Nonethe-
less, superposition of the bright field in consequent slices 
along the Z-axis of a single hMSC revealed that aggre-
gates of SiO2-NPs were spread along the entire thickness 
of the cell engrafted between cardiac fibres (Fig. 7b).
Conclusions
Here we demonstrate that internalized 50 nm SiO2-NPs 
do not lead to long-term cyto- or genotoxic outcomes 
in cultured hMSCs, with concomitant preservation 
Fig. 6 Imaging of SiO2-NPs -labelled hMSCs inside infarcted hearts. a Reconstruction of a 10 µm transverse slice to show the distribution of labelled 
hMSCs in infarcted hearts. White points: clusters of hMSCs. Red line: perimeter of cell distribution inside infarcted ventricles. b Subset illustrating 
labelled hMSCs (red) clustered inside ventricular tissue. Magnification 5×, scale bar 200 µm. c Representative confocal reconstruction with superpo-
sition of bright field, hMSCs (red) and nuclei (blue). The white dotted line is the perimeter of the volume representation in (d) to underline the higher 
co-localization between labelled hMSCs (red) and nuclei (blue) due to major cell aggregation typical of the injured area. Magnification 40×, scale 
bar 50 µm
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of stemness and proliferative properties of these cells. 
Moreover, findings on the beating hearts demonstrate 
that fluorescently labelled SiO2-NPs allow appropriate 
imaging and distribution of hMSCs in both normal and 
injured hearts.
A couple of methodological considerations need to 
be briefly outlined. First, one limitation of the isolated 
heart model might be the restricted time (in this case 6 h) 
offered before deterioration of the experimental prepara-
tion; however, for this study it resulted more accessible 
with respect to the in vivo counterpart, especially during 
simulation of I/R, due to excluded external interferences of 
neuro-hormonal responses, endothelial/neutrophil influ-
ence or massive inflammatory responses [41, 42]. Second, 
limited tissue penetrability of fluorescence might restrict 
the in vivo application of fluorescently labelled SiO2-NPs 
for SCs tracking. Yet, the ease of functionalization of these 
silica platforms and their biosafety might be exploited to 
entrap inside them contrast agents allowing more pen-
etrating and non invasive imaging, such as magnetic reso-
nance and ultrasound, which have already been applied in 
cardiac regenerative medicine [14, 43, 44].
Taken together, our protocol of 16  h exposure of 
hMSCs to 50  nm SiO2-NPs at the dose of 50  µg  mL−1 
possess powerful features of biosafety and compatibility 
that make these NPs suitable candidates for proper and 
potentially harmless labelling oriented to SCs tracking 
inside the heart. For the final purpose of obtaining long-
term and non-invasive cell imaging in in  vivo models, 
encapsulation of more penetrating contrast agents inside 
SiO2-NPs will enhance the applicability of these powerful 
core shells.
Fig. 7 Ultrastructural analysis of labelled hMSCs engrafted inside ventricular tissue. Representative confocal reconstruction of a normal ventricle. a 
Superposition of sarcomeric α-actinin staining (green) and SiO2-NPs internalized in hMSCs (red). Magnification 100×, scale bar 20 µm. b Consequent 
slices along the Z-axis from the subset in A (dashed perimeter), to display morphological rearrangement of a hMSC between cardiac fibers; superpo-
sition of α-actinin (green), SiO2-NPs (red) and correspondent bright field to reveal cell body
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Methods
Drugs and SiO2‑NPs
All drugs were purchased by Sigma, unless directly men-
tioned. Chemical composition and preparation of red 
fluorescent cyanine dye-doped SiO2-NPs “IRIS Dots” are 
detailed elsewhere [22]. Obtained SiO2-NPs exhibited a 
diameter of 50 ± 2 nm, possessed elevated morphologic 
homogeneity and displayed bright fluorescence emission 
and high photostability. An aliquot of pure SiO2-NPs was 
prepared without the addition of the fluorophore and 
used to evaluate ROS production, surface phenotype and 
differentiation potential of hMSCs.
Culture and treatment of hMSCs
hMSCs isolated from the bone marrow of healthy donors 
were commercially obtained from Lonza (Lonza Group 
Ltd., Switzerland) and were used for experiments at pas-
sages 4–8. Briefly, hMSCs were cultured in DMEM sup-
plemented with 1  % sodium pyruvate, 1  % nonessential 
amino acids, 1  % kanamycin, 1  % l-glutamine, 0.1  % 
β-mercaptoethanol (complete DMEM) and 10  % fetal 
bovine serum (FBS, Euroclone, Italy) (standard medium) 
and kept in an atmosphere of 5 % CO2, 95 % air at 37 °C 
in a humidified incubator. After reaching 80  % conflu-
ence, cells were detached using 0.25 % trypsin-ethylene-
diamine-tetra acetate (EDTA) 1 mmol·L−1, counted with 
a Neubauer chamber, seeded at the density of 6500 cell 
cm−2, given 24  h to settle and then incubated with the 
two following protocols: (a) SiO2-NPs: cells were exposed 
for 16 h with a suspension of water dissolved SiO2-NPs 
50 µg·mL−1 in complete DMEM/1 % FBS; (b) Untreated 
(UT): cells were incubated for 16  h with complete 
DMEM/1  % FBS supplemented with the same volume 
of sterile H2O in which SiO2-NPs were dispersed. Sub-
sequently, samples of both conditions were washed twice 
with warm phosphate-buffered saline (PBS, Euroclone) 
and analysed after the treatment (t0) or after 1 (R 1d), 3 
(R 3d) and 7 days (R 7d) of in vitro recovery in standard 
medium.
Confocal microscopy
The inverted confocal laser scanning microscope LSM 
510 (488 and 568 nm excitation wavelengths, Carl Zeiss, 
Germany) equipped with 5× (N.A. 0.15), 63× (N.A. 
1.40, oil immersion) and 100× (N.A. 1.13, oil immer-
sion) objectives was used to obtain XY images or stacks 
along the Z-axis without nuclei counterstaining (co-
localization between SiO2-NPs and lysosomes; recon-
struction of whole ventricular sections; ultrastructural 
analysis of heart samples). The TCS SP5 confocal laser 
microscopy system (Diode 405, Argon and He–Ne lasers, 
Leica Microsystem S.r.l., Italy) equipped with 40× (N.A. 
1.25, oil immersion) and 63× (N.A. 1.40, oil immersion) 
objectives was used to obtain stacks along the Z-axis with 
nuclei counterstaining (labelling rate, intracellular persis-
tence and interaction of SiO2-NPs with nuclei in cultured 
hMSCs; detection of γH2AX nuclear foci in cultured 
hMSCs; 40× analysis of ventricular sections).
Representative images presented in this study were 
processed with: ImageJ® (Rasband, W.S., ImageJ, U.S. 
National Institutes of Health, Bethesda, MD, USA, http://
www.rsb.info.nih.gov/ij/, 1997–2015) for reconstructions 
along the Z-axis of confocal stacks and for juxtaposi-
tions of XY images (5x magnification) to obtain whole 
transverse sections; Imaris (BitPlane AG, version 7.2.3) 
for volume representations of SiO2-NPs interaction with 
nuclei and heart tissue sections (Surpass viewer) and for 
representation of consequential slices (Gallery viewer).
hMSCs labelling with SiO2‑NPs and analysis of ROS 
production
hMSCs treated onto glass coverslips were washed twice 
with PBS and fixed for 15  min room temperature (r.t.) 
with cold 4 % paraformaldehyde (PAF) in PBS (pH 7.3). 
After nuclear counterstaining with Hoechst-33342 5  µg 
mL−1 for 15 min r.t, coverslips were mounted onto glass 
slides with Mowiol (Calbiochem, USA) and conserved 
at 4  °C. The labelling rate at t0 was quantified by flow 
cytometry: both UT and SiO2-NPs -treated cells were 
harvested, collected with a CyAN ADP flow cytometer 
(at least 30,000 events per sample) and analysed with 
Summit 4.3 software (Beckman Coulter, USA). Autofluo-
rescence of UT cells was previously subtracted from the 
analysis, data were presented in a histogram of number 
of events (Counts) vs. FL-2 Log (FL-2) and labelled cells 
were quantified as percentage of the total population.
To mark late endosomes and lysosomes, cells treated 
onto glass-bottomed dishes (MatTeck, USA) were 
incubated 15  min at 37° C with the fluorescent dye 
LysoTracker Green 2 µmol L−1 (Life Technologies, Italy) 
in complete DMEM, washed with sterile PBS and ana-
lysed with confocal microscopy. For each time point, 
quantification of co-localization was expressed as mean 
Pearson’s R value, calculated with the ImageJ® tool “Co-
localization finder”.
To evaluate ROS production in hMSCs, cells seeded 
in Nunc™ black flat-bottomed 96-wells (Thermo Fisher 
Scientific, USA) underwent UT or SiO2-NPs protocols, 
whereas treatment for 2  h with or hydrogen peroxide 
(H2O2) 600 µmol L−1  was used as a positive control for 
induction of oxidative stress. Samples were washed with 
PBS and incubated for 30 min at 37  °C in the dark with 
the specific probe Di Chloro-dihydro-Fluorescein Di 
Acetate (DCFH-DA) 10  µmol L−1 dissolved in standard 
medium w/o phenol red. Fluorescence emission (excita-
tion filter: 485 ±  20  nm; emission filter: 535 ±  25  nm) 
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was read with an Infinite F200 microplate reader (Tecan 
Group Ltd., Switzerland) and data from each sample were 
normalized on UT value.
SiO2‑NPs‑dependent cyto‑ and genotoxicity
hMSCs survival was evaluated by collecting both 
detached and adherent cells to incubate them for 5 min 
r.t. in the dark with a solution of propidium iodide (PI) 
1 µg·mL−1 in cold PBS. At least 30,000 events per sample 
were collected with a CyAN ADP flow cytometer, viable 
cells were evaluated on FL-2 Log (PI) vs. Forward Scatter 
Lin (FS) plots and expressed as percentage of living cells 
respect to the relative UT time-point.
Genotoxic stress was analysed by detecting nuclear 
foci of the histone γH2AX. hMSCs 1 h after 10 Gy irra-
diation were used as a positive control for the reaction. 
Briefly, cells treated onto glass coverslips were washed 
with PBS, fixed for 15 min with cold 4 % PAF, permeabi-
lized for 15 min with 0.1 % Triton X-100 and blocked for 
30 min with a solution of 6 % wt/vol bovine serine albu-
min (BSA) and 2.5  % normal goat serum (NGS) in PBS 
(all at r.t.). Incubation for 3  h at 4  °C with the primary 
antibody mouse anti-phospho H2AXSer136 (γH2AX, clone 
JBW301, Millipore, USA) 1:500 in PBS was followed by 
staining for 30 min at 37 °C with the secondary antibody 
anti-mouse Alexa Fluor 488 (Life Technologies) 1:500 
in PBS. After nuclear staining for 15  min r.t. with Hoe-
chst-33342 5  µg  mL−1, coverslips were mounted onto 
glass slides and conserved at 4 °C. Quantification of these 
experiments was assessed with confocal microscopy by 
random counting at least 250 cells per sample to obtain 
the per cent number of cells with nuclear foci (γH2AX 
positive cells) respect to the total considered population.
SiO2‑NPs persistence inside hMSCs and assessment 
of proliferation potential
The time course of SiO2-NPs persistence inside hMSCs 
was evaluated on cells treated onto glass coverslips 
through immunofluorescence and confocal microscopy. 
Quantification was assessed with the same method used 
for γH2AX foci by random counting at least 250 cells per 
sample to obtain the per cent labelled cells (SiO2-NPs-
hMSCs) respect to the total considered population.
Proliferation during in  vitro culture was evaluated 
via cell counting: hMSCs treated into T25 flasks (Corn-
ing, USA) were harvested and counted with a Neubauer 
chamber considering 8 quadrants for each sample. Pro-
liferation potential was expressed as “Cumulative Popula-
tion Doubling Level” (CPDL) according to Yu et al. [45].
Characterization of hMSCs surface phenotype
For each time point cells were harvested, washed with 
PBS supplemented with 1 % FBS and stained for 30 min 
at 4  °C with the following antibodies (1:10 in PBS,  BD 
Pharmingen, USA): anti-CD90, anti-CD29, anti-CD166 
(all conjugated with phycoerythrin PE); anti-CD105, 
anti-CD34, anti-CD45, anti-CD107, anti-HLA-DR, 
anti-CD14, anti-CD44 (all conjugated with fluorescein 
isothiocyanate FITC); anti-CD73 (conjugated with allo-
phycocyanin APC, MiltenyiBiotec, Germany). Cells were 
then suspended in cold PBS, at least 30,000 events per 
sample were collected with CyAN ADP flow cytometer 
and subsequent histograms of number of events (Counts) 
vs. Fluorescence Log (FL) were obtained.
In vitro adipogenic and osteogenic differentiation
After the treatments cells were seeded in 24-well plates 
at the density of 20,000 cells cm−2, given 24  h to settle 
and then treated for differentiation induction as previ-
ously described [46]. Briefly, adipose differentiation was 
induced with a specific adipogenic medium composed 
of standard medium supplemented with dexamethasone 
1  µmol L−1, isobutylmethylxanthine (IBMX) 500  µmol 
L−1, indomethacin 100 µmol L−1and insulin 10 µg·mL−1. 
Medium was replaced twice a week until day 18, when 
lipid droplets were counterstained with Oil Red: samples 
at r.t. were washed with PBS, fixed 1 h with 10 % formalin 
neutral buffer solution, washed twice with distilled H2O, 
incubated 5 min with 60 % isopropanol and then treated 
30  min with a solution of Oil Red 0.5 w/vol in 60  % 
isopropanol.
Osteogenic commitment was induced by means of a 
specific medium composed of standard medium sup-
plemented with dexamethasone 100  nmol  L−1, glycerol 
2-phosphate 10  mmol L−1 and ascorbic acid 200  µmol 
L−1. Medium was changed twice a week until day 21, 
when extracellular calcium salts were revealed through 
Alizarin Red staining. Briefly, cells at r.t. were washed 
with PBS, fixed 1  h with 70  % ethanol, washed twice 
with distilled H2O and incubated 45 min with a solution 
of Alizarin Red 40 mmol  L−1 (pH 4.2). For both assays, 
bright field images of morphological commitment at ter-
minal differentiation were taken with a digital camera 
(Moticam 580) mounted on an optical inverted micro-
scope (AE 2000, Motic, Spain) supplemented with 4× 
and 10× objectives. Representative images were then 
processed with ImageJ®.
Perfusion of isolated rat hearts and injection 
of SiO2‑NPs‑hMSCs
This study conforms to the Guide for the Care and Use 
of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85–23, revised 
1996) and in accordance with the Italian ethical guide-
lines (L 96, 6 August 2013). The local ethical commit-
tee approved the research project. Experiments were 
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performed on adult male Wistar rats (body-weight 450–
550  g). Animals were heparinized (2500 U I.m., Roche, 
Italy) and anaesthetized with urethane (1 g/kg i.p.) 10 min 
later. The hearts were rapidly excised, cannulated via the 
aorta and retrogradely perfused with oxygenated Krebs-
Henseleit buffer containing (in mmol·L−1) 127 NaCl, 17.7 
NaHCO3, 5.1 KCl, 1.5 CaCl2, 1.26 MgCl2 and 11 d-glu-
cose, supplemented with 5 µgm·L−1 lidocaine. A constant 
flow was adjusted with a proper pump (Watson-Marlow 
313, UK) to obtain a typical coronary perfusion pressure 
of 80–85  mm Hg during initial stabilization. Thereafter, 
the same flow level (9 ± 1 mL·min−1g−1) was maintained 
throughout the experiment. Temperature of perfusate 
and hearts were kept constant at 37° C throughout the 
experiments.
Hearts were divided into two groups, normal and 
infarcted hearts, presented in Additional file  4. In nor-
mal hearts (Additional file 4 Panel A, n = 3), hMSCs were 
injected in the apex 90  min after the start of retrograde 
perfusion. In infarcted hearts (Additional file  4 Panel B, 
n = 4), after 30 min stabilization, the LDCA was occluded 
for 30  min (Additional file  4 Panel B, “Ischemia”, recog-
nized by pale-coloured tissue after coronary occlusion 
and by a fall in left ventricular developed pressure) and 
then re-opened to full re-flow of the left ventricle (Addi-
tional file 4 Panel B, “Reperfusion”). hMSCs were injected 
in the apex after 30 min of re-oxygenation. All the experi-
ments were stopped after total 6  h of retrograde perfu-
sion, as this time was considered the end-point for proper 
ex vivo experiments, according to Penna et al. [41].
Heart processing and immunofluorescence analysis 
of tissue slices
At the end of perfusion, atria and vasa were discarded 
and ventricles were fixed for 3 h r.t. with 4 % PAF with 
gentle stirring. Tissues were then washed with PBS, sub-
merged in a solution of 30 % sucrose in PBS, allowed pre-
cipitating overnight at 4 °C and then incubated 30 min r.t. 
in a solution 1:1 of 30 % sucrose in PBS and TissueTek® 
Optimal Cutting Temperature (O.C.T.™, Sakura Fine-
Tek, USA). Finally, tissues were embedded in O.C.T. 
and stored at −80 °C. 10 µm thick transverse slices were 
obtained starting from the apex with a CM 1900 cry-
ostat (Leica Microsystem S.r.l.), placed onto Superfrost™ 
glass slides (Thermo Scientific, USA) and conserved at 
−20  °C. Sections used for ventricle reconstructions and 
40× analyses were rinsed with PBS and, after nuclear 
staining for 15  min r.t. with Hoechst-33342 5  µg  mL−1, 
they were mounted with Mowiol and conserved at 4 °C. 
Sections for ultrastructural analysis were processed for 
immunofluorescence. Briefly, they were rinsed in PBS, 
permeabilized for 20 min r.t. with 0.5 % Triton X-100 and 
blocked for 1 h r.t. with 6 % BSA and 2.5 % NGS in PBS. 
The primary antibody mouse anti-sarcomeric α-actinin 
1:600 in PBS was incubated overnight 4 °C, whereas the 
secondary antibody anti-mouse Alexa Fluor 488 1:1000 
in PBS was incubated for 1  h r.t. Finally, samples were 
mounted with Mowiol and conserved at 4 °C.
Statistical Analysis
Data are expressed as mean ± standard error of the mean 
(S.E.M.) of at least three different experiments. Statisti-
cal comparisons were performed with Student’s t test or 
one-way analysis of variance (ANOVA) with Bonferroni 
correction. Differences with p  ≤  0.05 were regarded as 
statistically significant.
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dense extracellular matrix. Magnification 10x, scale bar 100 µm.
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In both groups, SiO2-NPs -treated hMSCs were injected in the apex after 
90 min from the start of retrograde perfusion.
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